Terms: = Uterine cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Staging
6 results:
1. Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer.
Yang Q; Zhou Q; He X; Cai J; Sun S; Huang B; Wang Z
J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102145. PubMed ID: 33848645
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative prediction of deep myometrial invasion and tumor grade for stage I endometrioid adenocarcinoma: a simple method of measurement on DWI.
Yan B; Liang X; Zhao T; Niu C; Ding C; Liu W
Eur Radiol; 2019 Feb; 29(2):838-848. PubMed ID: 30039225
[TBL] [Abstract] [Full Text] [Related]
4. Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the National cancer Database.
Nieto K; Adams W; Pham N; Block AM; Grover S; Small W; Harkenrider MM
Gynecol Oncol; 2018 Jan; 148(1):147-153. PubMed ID: 29129389
[TBL] [Abstract] [Full Text] [Related]
5. SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients.
Antonsen SL; Loft A; Fisker R; Nielsen AL; Andersen ES; Høgdall E; Tabor A; Jochumsen K; Fagö-Olsen CL; Asmussen J; Berthelsen AK; Christensen IJ; Høgdall C
Gynecol Oncol; 2013 May; 129(2):298-303. PubMed ID: 23376805
[TBL] [Abstract] [Full Text] [Related]
6. Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study.
Ismail H; Ho KM; Narayan K; Kondalsamy-Chennakesavan S
Br J Anaesth; 2010 Aug; 105(2):145-9. PubMed ID: 20573631
[TBL] [Abstract] [Full Text] [Related]
